Egr1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| EGR1 Gene | |
|---|---|
| Full Name | Early Growth Response 1 |
| Chromosome | 5q31.2 |
| NCBI Gene ID | 1958 |
| OMIM | 129500 |
| Ensembl ID | ENSG00000120738 |
| UniProt ID | P18146 |
| Encoded Protein | EGR1 |
| Associated Diseases | Alzheimer's disease, Parkinson's disease, stroke, cancer |
The EGR1 gene (Early Growth Response 1) encodes a zinc-finger transcription factor that serves as an immediate-early gene induced by neuronal activity, growth factors, and cellular stress. EGR1 plays critical roles in synaptic plasticity, memory consolidation, and neuronal survival. Dysregulated EGR1 expression has been associated with Alzheimer's disease, Parkinson's disease, and Huntington's disease.
EGR1 is an immediate-early transcription factor that regulates neuronal plasticity, learning, memory, and response to neural activity. It is induced by synaptic activity and regulates expression of genes involved in synaptic strength and neuronal survival.
Immediate-early gene induced in neurons by synaptic activity, calcium influx, and growth factors. Expressed throughout the brain, with high levels in hippocampus and cortex.
EGR1 is dysregulated in Alzheimer's disease and Parkinson's disease. It may have neuroprotective roles by regulating expression of neurotrophic factors and anti-apoptotic proteins. Reduced EGR1 activity may contribute to memory impairment in AD.
EGR1 (Early Growth Response 1) is an immediate early gene that acts as a zinc-finger transcription factor. Upon neuronal activation, EGR1 is rapidly induced and regulates downstream target genes involved in:
EGR1 interacts with CREB and other transcription factors to coordinate activity-dependent gene expression. It also participates in epigenetic regulation by recruiting histone acetyltransferases to target gene promoters.
EGR1-based therapeutic strategies include:
Current research areas:
The study of Egr1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
EGR1 (Early Growth Response 1) is an immediate early gene that acts as a zinc-finger transcription factor. Upon neuronal activation, EGR1 is rapidly induced and regulates downstream target genes involved in:
EGR1 interacts with CREB and other transcription factors to coordinate activity-dependent gene expression. It also participates in epigenetic regulation by recruiting histone acetyltransferases to target gene promoters.
EGR1-based therapeutic strategies include:
Current research areas: